Table 1 Baseline Characteristics of Patients.
Characteristics | ADPKD Group (N = 557) | Non-ADPKD Group (N = 1671) | P |
|---|---|---|---|
Age, years, mean (SD) | 56.0 (12.6) | 55.0 (14.7) | 0.920 |
Gender | |||
Male | 282 (50.6) | 837 (50.1) | 0.826 |
Female | 275 (49.4) | 834 (49.9) | |
CCI score, mean (SD) | 4.7 (2.2) | 4.6 (2.2) | 0.852 |
AVF | 505 (90.7) | 1516 (90.7) | 0.966 |
Concomitant medications | |||
Antiplatelet agents‡ | 148 (26.6) | 452 (27.0) | 0.825 |
ACE inhibitor or ARB | 225 (40.4) | 672 (40.2) | 0.940 |
Beta blocker | 283 (50.8) | 849 (50.8) | >0.99 |
Calcium channel blocker | 392 (70.4) | 1140 (68.2) | 0.342 |
Statin | 40 (7.2) | 119 (7.1) | 0.962 |
Comorbidities | |||
Diabetes mellitus | 157 (28.2) | 433 (25.9) | 0.292 |
Hypertension | 531 (95.3) | 1597 (95.6) | 0.813 |
Myocardial infarction | 23 (4.1) | 68 (4.1) | 0.951 |
Heart failure | 100 (18.0) | 305 (18.3) | 0.874 |
Peripheral vascular disease | 30 (5.4) | 82 (4.9) | 0.654 |
Dementia | 15 (2.7) | 45 (2.7) | >0.99 |
Chronic pulmonary disease | 219 (39.3) | 653 (39.1) | 0.920 |
Dyslipidemia | 211 (37.9) | 643 (38.5) | 0.801 |
Cerebrovascular disease | 150 (26.9) | 420 (25.1) | 0.400 |
Valvular heart disease | 54 (9.7) | 144 (8.6) | 0.439 |
Cancer | 96 (17.2) | 266 (15.9) | 0.466 |
